Evidence for direct and sleep‐moderated relationships between aquaporin‐4 genetic variants and Alzheimer's disease phenotypes
Alzheimer's & Dementia · 2026-06 · 22 (6)
DOI: 10.1002/alz.71516 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 29.05.2026. Verfasst von Tenielle Porter und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Precision Health, Edith Cowan University, Joondalup, Western Australia, Australia. Hauptthemen laut MEDLINE: Aquaporin 4, Alzheimer Disease, Sleep, Sleep Wake Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alzheimer's Association (USA), Alzheimer's Drug Discovery Foundation, the NHMRC.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Variants in the aquaporin‐4 gene ( AQP4 ) have been associated with Alzheimer's disease (AD) diagnosis, cognition, and brain amyloid beta (Aβ) and may affect the sleep and Aβ relationship. Their association with other AD‐related phenotypes/disease progression remain largely unknown. METHODS Associations between AQP4 variants, self‐reported sleep measures, and AD‐related phenotypes in cognitively unimpaired individuals with evidence of Aβ accumulation were examined using data from the Australian Imaging, Biomarkers and Lifestyle study. RESULTS AQP4 variants were directly associated with regional brain volumes, atrophy, and cognition. They were also associated with differences in regional brain volumes and atrophy in interaction with sleep duration, latency, and quality. Finally, AQP4 variants were associated with cognitive decline in interaction with sleep disturbances. DISCUSSION These findings support a relationship between AQP4 and AD phenotypes, both directly and through their interaction with sleep.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Precision Health, Edith Cowan University, Joondalup, Western Australia, Australia.
- Collaborative Genomics and Translation Group, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
- Curtin Medical School, Curtin University, Bentley, Western Australia, Australia.
- Australian E-Health Research Centre, CSIRO, Parkville, Victoria, Australia.
- Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, Victoria, Australia.
- Australian E-Health Research Centre, CSIRO, Herston, Queensland, Australia.
ORCID-Profile: Simon M Laws
Förderung
- Alzheimer's Association (USA)
- Alzheimer's Drug Discovery Foundation
- the NHMRC
- NHMRC Investigator
Zitieren
APA
Porter, T., Armstrong, A. M., O'Brien, E. K., Doré, V., Bourgeat, P., Turner, M., Maruff, P., Rowe, C. C., Brown, B. M., Villemagne, V. L., Rainey-Smith, S. R., Laws, S. M., & AIBL Research Group (2026). Evidence for direct and sleep‐moderated relationships between aquaporin‐4 genetic variants and Alzheimer's disease phenotypes. Alzheimer's & Dementia, 22(6). https://doi.org/10.1002/alz.71516
Vancouver
Porter T, Armstrong AM, O'Brien EK, Doré V, Bourgeat P, Turner M, et al. Evidence for direct and sleep‐moderated relationships between aquaporin‐4 genetic variants and Alzheimer's disease phenotypes. Alzheimer's & Dementia. 2026;22(6). doi:10.1002/alz.71516
BibTeX
@article{Porter2026,
author = {Porter, Tenielle and Armstrong, Ayeisha Milligan and O'Brien, Eleanor K and Doré, Vincent and Bourgeat, Pierrick and Turner, Mitchell and Maruff, Paul and Rowe, Christopher C and Brown, Belinda M and Villemagne, Victor L and Rainey-Smith, Stephanie R and Laws, Simon M and AIBL Research Group, AIBL Research Group},
title = {Evidence for direct and sleep‐moderated relationships between aquaporin‐4 genetic variants and Alzheimer's disease phenotypes},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {6},
doi = {10.1002/alz.71516}
}
EUVIMED